| __timestamp | BioMarin Pharmaceutical Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 22622695 |
| Thursday, January 1, 2015 | 152008000 | 24863028 |
| Friday, January 1, 2016 | 209620000 | 21351001 |
| Sunday, January 1, 2017 | 241786000 | 53837297 |
| Monday, January 1, 2018 | 315264000 | 16080096 |
| Tuesday, January 1, 2019 | 359466000 | 18525736 |
| Wednesday, January 1, 2020 | 524272000 | 2024000 |
| Friday, January 1, 2021 | 470515000 | 2548000 |
| Saturday, January 1, 2022 | 483669000 | 61556000 |
| Sunday, January 1, 2023 | 577065000 | 188157000 |
| Monday, January 1, 2024 | 580235000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Over the past decade, BioMarin Pharmaceutical Inc. and Telix Pharmaceuticals Limited have shown contrasting trends in their cost of revenue. BioMarin's cost of revenue has surged by approximately 345% from 2014 to 2023, reflecting its expanding operations and market reach. In contrast, Telix, a relatively newer player, has seen a staggering increase of over 730% in the same period, indicating rapid growth and scaling efforts.
These trends highlight the strategic differences between an established giant and an emerging contender in the pharmaceutical landscape.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Telix Pharmaceuticals Limited
Cost of Revenue Trends: BeiGene, Ltd. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: United Therapeutics Corporation vs Telix Pharmaceuticals Limited
Cost of Revenue Trends: Viatris Inc. vs Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Intra-Cellular Therapies, Inc. and Telix Pharmaceuticals Limited
BioMarin Pharmaceutical Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: BioMarin Pharmaceutical Inc. vs Wave Life Sciences Ltd.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Galapagos NV
Cost Insights: Breaking Down Telix Pharmaceuticals Limited and MorphoSys AG's Expenses
Cost of Revenue: Key Insights for Telix Pharmaceuticals Limited and Supernus Pharmaceuticals, Inc.
Telix Pharmaceuticals Limited vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Telix Pharmaceuticals Limited and Xencor, Inc.